696 related articles for article (PubMed ID: 25562430)
1. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
2. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade.
Ehlting C; Lai WS; Schaper F; Brenndörfer ED; Matthes RJ; Heinrich PC; Ludwig S; Blackshear PJ; Gaestel M; Häussinger D; Bode JG
J Immunol; 2007 Mar; 178(5):2813-26. PubMed ID: 17312125
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
5. IL-1β-induced and p38
Kulawik A; Engesser R; Ehlting C; Raue A; Albrecht U; Hahn B; Lehmann WD; Gaestel M; Klingmüller U; Häussinger D; Timmer J; Bode JG
J Biol Chem; 2017 Apr; 292(15):6291-6302. PubMed ID: 28223354
[TBL] [Abstract][Full Text] [Related]
6. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
7. Distinctive pro-inflammatory gene signatures induced in articular chondrocytes by oncostatin M and IL-6 are regulated by Suppressor of Cytokine Signaling-3.
Liu X; Liu R; Croker BA; Lawlor KE; Smyth GK; Wicks IP
Osteoarthritis Cartilage; 2015 Oct; 23(10):1743-54. PubMed ID: 26045176
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
11. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases.
Böing I; Stross C; Radtke S; Lippok BE; Heinrich PC; Hermanns HM
Cell Signal; 2006 Jan; 18(1):50-61. PubMed ID: 15935618
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
El Mabrouk M; Sylvester J; Zafarullah M
Biochim Biophys Acta; 2007 Mar; 1773(3):309-20. PubMed ID: 17208315
[TBL] [Abstract][Full Text] [Related]
15. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling.
Pollack V; Sarközi R; Banki Z; Feifel E; Wehn S; Gstraunthaler G; Stoiber H; Mayer G; Montesano R; Strutz F; Schramek H
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1714-26. PubMed ID: 17881458
[TBL] [Abstract][Full Text] [Related]
18. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
